ARCH Venture Fund X, L.P. 13D and 13G filings for Maze Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 5:05 pm Purchase | 2025-03-31 | 13G | Maze Therapeutics, Inc. MAZE | ARCH Venture Fund X, L.P. | 4,120,053 9.400% | 4,120,053 (New Position) | Filing |